Her main research concerns Internal medicine, Surgery, Thrombosis, Gastroenterology and Cancer. In Internal medicine, she works on issues like Oncology, which are connected to Biomarker and Disease. Her Surgery study combines topics from a wide range of disciplines, such as Clinical trial, Pediatrics and Splenectomy.
The study incorporates disciplines such as Pulmonary embolism and Retrospective cohort study in addition to Thrombosis. Ingrid Pabinger interconnects Interquartile range, Pharmacokinetics, Coagulation and Immunology in the investigation of issues within Gastroenterology. Ingrid Pabinger has included themes like Chemotherapy, Cohort study, Pathology, Population study and Hazard ratio in her Cancer study.
Ingrid Pabinger mainly focuses on Internal medicine, Thrombosis, Surgery, Gastroenterology and Cancer. Her study explores the link between Internal medicine and topics such as Immunology that cross with problems in Disseminated intravascular coagulation. Her Thrombosis research includes elements of Pregnancy, Antithrombin and Pediatrics.
Her research integrates issues of Adverse effect and Clinical trial in her study of Surgery. Her Gastroenterology study integrates concerns from other disciplines, such as Odds ratio, Interquartile range, Chemotherapy, Coagulation and Confidence interval. Ingrid Pabinger has researched Cancer in several fields, including Cohort study, Oncology, Venous thromboembolism, Intensive care medicine and Hazard ratio.
Her scientific interests lie mostly in Internal medicine, Cancer, In patient, Thrombosis and Confidence interval. Her Internal medicine research includes themes of Gastroenterology and Oncology. Her Gastroenterology study incorporates themes from Progressive disease, Interquartile range, Fibrinolysis, ABO blood group system and Von Willebrand factor.
Her study looks at the relationship between Cancer and topics such as Prospective cohort study, which overlap with Risk of mortality. Her Thrombosis research incorporates themes from Thrombus and Clinical trial. The Confidence interval study combines topics in areas such as Pulmonary embolism, Incidence and Cohort.
Ingrid Pabinger spends much of her time researching Internal medicine, Confidence interval, Cancer, Thrombosis and In patient. The concepts of her Internal medicine study are interwoven with issues in Gastroenterology and Bleed. Her biological study spans a wide range of topics, including Brain damage, Histone H3, Incidence and Disease.
In her study, which falls under the umbrella issue of Cancer, Offspring, Pregnancy, Genetic predisposition, Retrospective cohort study and Azathioprine is strongly linked to Prospective cohort study. As part of her studies on Thrombosis, Ingrid Pabinger often connects relevant subjects like Systemic lupus erythematosus. Her work focuses on many connections between Meta-analysis and other disciplines, such as Discontinuation, that overlap with her field of interest in Venous thrombosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Shannon M. Bates;Ian A. Greer;Ingrid Pabinger;Shoshanna Sofaer.
Increased fetal loss in women with heritable thrombophilia
FE Preston;FR Rosendaal;ID Walker;E Briët.
The Lancet (1996)
Prediction of venous thromboembolism in cancer patients
Cihan Ay;Daniela Dunkler;Christine Marosi;Alexandru-Laurentiu Chiriac.
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D Farge;P Debourdeau;M Beckers;C Baglin.
Journal of Thrombosis and Haemostasis (2013)
D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study
Cihan Ay;Rainer Vormittag;Daniela Dunkler;Ralph Simanek.
Journal of Clinical Oncology (2009)
Wilson's disease in patients presenting with liver disease: A diagnostic challenge
P Steindl;P Ferenci;H P Dienes;G Grimm.
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
Johnny Mahlangu;Jerry S. Powell;Margaret V. Ragni;Pratima Chowdary.
Romiplostim or standard of care in patients with immune thrombocytopenia.
David J. Kuter;Mathias Rummel;Ralph Boccia;B. Gail Macik.
The New England Journal of Medicine (2010)
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
Cihan Ay;Ralph Simanek;Rainer Vormittag;Daniela Dunkler.
A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms
Damla Olcaydu;Ashot Harutyunyan;Roland Jäger;Tiina Berg.
Nature Genetics (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: